Wockhardt recalls hypertension drug in US

Wockhardt recalls hypertension drug in US

FPJ BureauUpdated: Saturday, June 01, 2019, 12:50 PM IST
article-image

Hyderabad:  Wockhardt Ltd is recalling 109,744 bottles of anti-hypertensive drug belonging to multiple lots from the American market following failure of dissolution test, US regulator FDA said.  According to a notification by the USFDA, the recall is voluntarily and was initiated by the company from April 1 under ‘Class-II’ classification.             The recall of metoprolol is a generic version of AstraZeneca Plc’s branded drug Toprol.

RECENT STORIES

Gold Falls ₹600 To ₹1,31,600/10g On Muted Global Trends, Rate-cut Jitters

Gold Falls ₹600 To ₹1,31,600/10g On Muted Global Trends, Rate-cut Jitters

Over 31.38 Crore Unorganised Workers Registered On e-Shram Portal; NCS Records 6.02 Crore Jobseekers

Over 31.38 Crore Unorganised Workers Registered On e-Shram Portal; NCS Records 6.02 Crore Jobseekers

Sberbank Launches First-India Mutual Fund Linking Russian Investors To Nifty50 Index

Sberbank Launches First-India Mutual Fund Linking Russian Investors To Nifty50 Index

PM Vishwakarma Scheme: 23.09 Lakh Artisans Trained, 6.8 Lakh Receive ₹22 Crore Incentives

PM Vishwakarma Scheme: 23.09 Lakh Artisans Trained, 6.8 Lakh Receive ₹22 Crore Incentives

VIDEO: 'India-Russia Trade Must Be More Balanced,' Says Minister Piyush Goyal; Target USD 100...

VIDEO: 'India-Russia Trade Must Be More Balanced,' Says Minister Piyush Goyal; Target USD 100...